Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

2.0%

8 terminated/withdrawn out of 400 trials

Success Rate

91.8%

+5.2% vs industry average

Late-Stage Pipeline

12%

49 trials in Phase 3/4

Results Transparency

4%

4 of 89 completed trials have results

Key Signals

102 recruiting4 with results5 withdrawn

Enrollment Performance

Analytics

N/A
133(54.3%)
Phase 2
44(18.0%)
Phase 4
28(11.4%)
Phase 3
21(8.6%)
Phase 1
10(4.1%)
Early Phase 1
9(3.7%)
245Total
N/A(133)
Phase 2(44)
Phase 4(28)
Phase 3(21)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (400)

Showing 20 of 400 trials
NCT06902740Phase 4Recruiting

PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis

Role: collaborator

NCT05384444Not ApplicableActive Not Recruiting

Effect of FMD on Colorectal Cancer Patients

Role: collaborator

NCT07644962Not Yet Recruiting

Research Project on the Interaction Between Immune Function and Infectious Diseases in Older Adults and the Development of Prevention and Control Strategies

Role: lead

NCT07620626Recruiting

Real-World Study of Woven EndoBridge for Intracranial Aneurysm Treatment

Role: collaborator

NCT07634068Phase 2Not Yet Recruiting

Vertebrobasilar Dolichoectasia Treatment With Amiloride

Role: lead

NCT07634120Phase 2Not Yet Recruiting

Vertebrobasilar Dolichoectasia Treatment With Sirolimus

Role: lead

NCT07604688Recruiting

Multicenter Registry Study of Patients With Intracranial Dural Arteriovenous Fistulas in China

Role: collaborator

NCT07571226Recruiting

Identification and Molecular Characterisation of Urban-environmental Stress Patterns Affecting Mental Illness

Role: lead

NCT06101940Enrolling By Invitation

Chinese Multicenter Clinical Outcome Cohort Study of Myotonic Dystrophy Type 1 (C-DMCOS-DM1)

Role: lead

NCT07607184Not Yet Recruiting

Multi-center Validation Study of a Large Language Model-based Intelligent Agent for Blood Cell Analysis

Role: lead

NCT07611695Not Yet Recruiting

Artificial Intelligence-driven Tuberculosis Landscape Analysis & Stratification Research

Role: lead

NCT05129904Active Not Recruiting

Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint (PADSTONE Study)

Role: collaborator

NCT07603752Not ApplicableRecruiting

Implantable Wireless Brain-Machine Interface System for Spinal Cord Injury: Efficacy and Safety Study

Role: collaborator

NCT03385902Not ApplicableCompleted

Assessment of Dialysis Initiation by a Fuzzy Mathematics Equation

Role: collaborator

NCT05494658Not ApplicableTerminated

Impact of Preoperative Oral Branched-chain Amino Acids on Reducing Postoperative Insulin Resistance.

Role: collaborator

NCT06284642Phase 4Recruiting

Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK)

Role: collaborator

NCT05146193Recruiting

AI-Powered Scoliosis Auto-Analysis System Multicenter Development and Validations

Role: collaborator

NCT06401772Not ApplicableRecruiting

The Effectiveness and Safety of Body Posture in Preventing Postoperative Recurrence for Chronic Subdural Hematoma

Role: lead

NCT07552792Not ApplicableNot Yet Recruiting

Impact of Hand Rub Placement on Patient Trust and Disease Stigma

Role: lead

NCT07538128Early Phase 1Recruiting

Evaluating Safety, Tolerability, and Preliminary Efficacy of YSCH-01 Monotherapy and in Combination With Atezolizumab for Recurrent Glioblastoma

Role: lead